NXS Financial Statements | Balance Sheet, Income & Cash Flow Analysis

The financial statements for NXS (NXS) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.

See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.

Financial Statements

Related peers

Compare More →
ROC
RocketBoots Limited
$0.30
-1.61%
HZN
Horizon Oil Limited
$0.23
+0.00%
CAN
Cann Group Limited
$0.01
+9.09%
KAR
Karoon Energy Ltd
$2.14
-2.73%
VLS
Vita Life Sciences Limited
$2.49
+0.00%
MVP
Medical Developments International Limited
$0.38
-5.06%

Frequently Asked Questions

What are NXS's latest financial results?

Review NXS's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.

How has NXS's revenue and net income changed over time?

Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.

What is NXS's cash flow situation and liquidity?

Cash flow statements reveal how NXS generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.

How does NXS's financial performance compare to industry peers?

Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether NXS is outperforming or lagging within its sector.

Are NXS's financial statements showing sustainable profitability?

By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether NXS's profits are repeatable and supported by strong fundamentals.